Exosome nasal spray and preparation method thereof
By using modified exosomes and thickeners in rhinitis spray, combined with phosphate buffer and heat shock protein treatment methods, the problem of short survival time of exosomes in rhinitis spray is solved, and the treatment effect and nasal moisturization are improved. .
Patent Information
- Application Number
- CN202411456568.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-18
- Publication Date
- 2024-11-15
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The long-term use of existing rhinitis sprays may lead to dryness and increased irritation in the nasal cavity, and the survival time of exosomes is short, affecting the therapeutic effect.
By adding modified exosomes to the nasal spray and using co-incubation method of phosphate buffer and heat shock protein, a stable protein membrane is formed, which improves the survival time of exosomes, and thickeners and antioxidants are added to Improves viscosity and stability.
It significantly improves the survival time and stability of exosomes, reduces the production of inflammatory mediators, promotes nasal mucosa repair, enhances treatment effect, and maintains the nasal moist state.
Smart Images

Figure SMS_1
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of sprays, and in particular relates to an exosome nasal spray and a preparation method thereof. Background Art
[0002] Rhinitis is an acute or chronic inflammation caused by damage to the nasal mucosa or submucosal tissue due to viral infection, bacterial infection, irritant stimulation, etc. Acute rhinitis is caused by viral infection, and is often accompanied by bacterial infection in the later stage, and is contagious. Chronic rhinitis is caused by inflammation that persists for several months or recurs repeatedly, and is not healed. It generally includes chronic simple rhinitis and chronic hypertrophic rhinitis. Other common rhinitis include: allergic rhinitis, dry rhinitis, atrophic rhinitis, vasomotor rhinitis, etc. The nasal cavity is the first gateway to the respiratory system, and it undertakes important tasks such as filtering, temperature regulation, disinfection and sterilization of the air. Nasal inflammation is bound to have a negative impact on its function. If it is not treated in time, the inflammation will spread to the sinuses, thereby affecting the health level of the whole body.
[0003] At present, most rhinitis sprays contain ingredients such as steroids and vasoconstrictors. Long-term use may cause nasal dryness and increased irritation, and there is a rebound effect after drug withdrawal, which affects the patient's use effect and experience. There is also a solution in the prior art to add exosomes to the spray, using the function of exosomes to improve the therapeutic effect of the spray, but due to the characteristics of the exosomes themselves, their survival time is very short, affecting the therapeutic effect. Summary of the invention
[0004] In view of the above-mentioned deficiencies in the prior art, the present invention provides an exosome nasal spray and a preparation method thereof. The nasal spray contains exosome components and the exosomes are modified to increase the survival time of the exosomes, thereby improving the therapeutic effect of the nasal spray on rhinitis.
[0005] To achieve the above purpose, the technical solution adopted by the present invention to solve the technical problem is: An exosome nasal spray comprises the following raw materials in weight percentage: 15-30% of modified exosomes, 1-2% of thickener, 0.01-0.1% of preservative, 1-3% of antioxidant, and the rest is sterile water; Among them, the modified exosomes are prepared by the following method: using phosphate buffer as a solvent, preparing a phosphatidylinositol-4,5-bisphosphate solution and a heat shock protein solution respectively, and then mixing the two solutions under a low temperature, oxygen-free, and light-proof environment, adding exosomes to the mixed solution, stirring and mixing and incubating, and removing the solvent after the incubation to obtain modified exosomes.
[0006] Furthermore, the following raw materials are included in weight percentage: 25% modified exosomes, 1.6% thickener, 0.1% preservative, 2.5% antioxidant, and the rest is sterile water.
[0007] Furthermore, during the preparation of modified exosomes, the pH value of the phosphate buffer was 7.2-7.4; the incubation temperature after adding the exosomes was 4-8°C, and the incubation time was 1-3h.
[0008] Furthermore, the mass ratio of exosomes, phosphatidylinositol-4,5-bisphosphate and heat shock protein is 1-2:0.5-1:0.5-1.
[0009] Furthermore, the exosomes are human mesenchymal stem cell exosomes.
[0010] Furthermore, the thickener includes xanthan gum and sodium hyaluronate, wherein the mass proportion of the xanthan gum in the nasal spray is 0.05-0.1%, and the mass proportion of the sodium hyaluronate in the nasal spray is 1-1.9%.
[0011] Furthermore, the preservative is benzyl alcohol.
[0012] Furthermore, the antioxidant is at least one of anthocyanin, vitamin C and carotenoid.
[0013] The method for preparing the exosome nasal spray comprises the following steps: (1) Add a thickener to sterile water and stir until dissolved to prepare a spray base solution; (2) Add a preservative and an antioxidant to the spray base liquid, stir evenly, adjust the pH value of the base liquid to 7.2-7.4, then add the modified exosomes thereto, stir and mix evenly, and fill to obtain the product.
[0014] The beneficial effects produced by the present invention are: 1. The nasal spray of the present invention contains exosome components, which can reduce the production of inflammatory mediators, inhibit the activation and proliferation of inflammatory cells, and promote cell proliferation and repair of nasal mucosa, thereby achieving the purpose of treating rhinitis.
[0015] 2. In the present invention, during the co-incubation of exosomes, phosphatidylinositol-4,5-bisphosphate and heat shock proteins, the heat shock proteins can bind to the exosomes and are closely arranged and attached to the surface of the exosomes. At the same time, phosphatidylinositol-4,5-bisphosphate can also bind to the heat shock proteins on the surface of the exosomes and the proteins of the exosomes themselves, and is used to anchor the heat shock proteins and the proteins of the exosomes themselves, so that a stable protein film is formed on the surface of the exosomes. The heat shock protein modified on the surface of the exosomes is a small molecule heat shock protein, which is heat-resistant and can improve the stability of the exosomes during storage, thereby increasing the storage time of the exosomes.
[0016] 3. The nasal spray of the present invention contains a thickener component, which can increase the viscosity of the spray, increase the retention time of the active ingredients in the nasal cavity, and thus improve the effect of the active ingredients; the thickener contains sodium hyaluronate, which has an excellent moisturizing effect and can keep the nasal mucosa moist, making it easier for exosomes to function.
[0017] 4. Antioxidants are added to the nasal spray of the present invention, which can reduce the oxidation of exosomes during storage and further improve the stability of exosomes. DETAILED DESCRIPTION
[0018] In order to make the purpose, technical scheme and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention, that is, the embodiments described are only part of the embodiments of the present invention, rather than all of the embodiments.
[0019] Therefore, the following detailed description of the embodiments of the present invention is not intended to limit the scope of the invention claimed for protection, but merely represents selected embodiments of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without making creative work are within the scope of protection of the present invention.
[0020] It should be noted that relational terms such as "first" and "second" are used only to distinguish one entity or operation from another entity or operation, and do not necessarily require or imply any such actual relationship or order between these entities or operations. Moreover, the terms "include", "comprises" or any other variants thereof are intended to cover non-exclusive inclusion, so that a process, method, article or device including a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements inherent to such process, method, article or device. In the absence of further restrictions, an element defined by the sentence "comprises a ..." does not exclude the existence of other identical elements in the process, method, article or device including the element.
[0021] The features and performance of the present invention are further described in detail below in conjunction with the embodiments.
[0022] Example 1 An exosome nasal spray, comprising the following raw materials in percentage by weight: 15% modified exosomes, 0.05% xanthan gum, 1.9% sodium hyaluronate, 0.01% benzyl alcohol, 1% anthocyanin, and the remainder being sterile water; The modified exosomes were prepared by the following method: placing phosphatidylinositol-4,5-bisphosphate in a phosphate buffer solution at 37°C and a pH value of 7.2, stirring until the phosphatidylinositol-4,5-bisphosphate was dissolved, and then filtering and sterilizing with a 0.22 μm filter membrane to obtain a phosphatidylinositol-4,5-bisphosphate solution; dissolving heat shock protein in a phosphate buffer solution at a pH value of 7.2, and then filtering and sterilizing with a 0.22 μm filter membrane to obtain a heat shock protein solution; separating The temperature of the phosphatidylinositol-4,5-bisphosphate solution and the heat shock protein solution were lowered to 4°C, and then the heat shock protein solution and the pre-prepared exosomes were added to the phosphatidylinositol-4,5-bisphosphate solution under an inert gas and light-proof environment, wherein the mass ratio of the exosomes, phosphatidylinositol-4,5-bisphosphate and the heat shock protein was 1:0.5:0.5, and the mixture was stirred and mixed, and incubated together for 1 hour. After the incubation, the solvent was filtered out, and the exosomes were rinsed with sterile water to obtain modified exosomes; The method for preparing the exosome nasal spray comprises the following steps: (1) Add xanthan gum and sodium hyaluronate to sterile water and stir until dissolved to prepare a spray base solution; (2) Add a preservative and an antioxidant to the spray base liquid, stir evenly, adjust the pH value of the base liquid to 7.2, then add the modified exosomes thereto, stir and mix evenly, and fill to obtain a spray base liquid.
[0023] Example 2 An exosome nasal spray comprises the following raw materials in percentage by weight: 30% modified exosomes, 0.1% xanthan gum, 1% sodium hyaluronate, 0.1% benzyl alcohol, 3% vitamin C, and the remainder being sterile water; The modified exosomes were prepared by the following method: placing phosphatidylinositol-4,5-bisphosphate in a phosphate buffer solution at 37°C and a pH value of 7.4, stirring until the phosphatidylinositol-4,5-bisphosphate was dissolved, and then filtering and sterilizing with a 0.22 μm filter membrane to obtain a phosphatidylinositol-4,5-bisphosphate solution; dissolving heat shock protein in a phosphate buffer solution at a pH value of 7.4, and then filtering and sterilizing with a 0.22 μm filter membrane to obtain a heat shock protein solution; separating The temperature of the phosphatidylinositol-4,5-bisphosphate solution and the heat shock protein solution were lowered to 8°C, and then the heat shock protein solution and the pre-prepared exosomes were added to the phosphatidylinositol-4,5-bisphosphate solution under an inert gas and light-proof environment, wherein the mass ratio of the exosomes, phosphatidylinositol-4,5-bisphosphate and the heat shock protein was 2:0.5:0.5, and the mixture was stirred and mixed, and incubated together for 3 hours. After the incubation, the solvent was filtered out, and the exosomes were rinsed with sterile water to obtain modified exosomes; The method for preparing the exosome nasal spray comprises the following steps: (1) Add xanthan gum and sodium hyaluronate to sterile water and stir until dissolved to prepare a spray base solution; (2) Add a preservative and an antioxidant to the spray base liquid, stir evenly, adjust the pH value of the base liquid to 7.4, then add the modified exosomes thereto, stir and mix evenly, and fill to obtain a spray base liquid.
[0024] Example 3 An exosome nasal spray comprises the following raw materials in percentage by weight: 20% modified exosomes, 0.06% xanthan gum, 1.3% sodium hyaluronate, 0.04% benzyl alcohol, 2% carotenoids, and the remainder is sterile water; The modified exosomes were prepared by the following method: placing phosphatidylinositol-4,5-bisphosphate in a phosphate buffer solution at 37°C and a pH value of 7.3, stirring until the phosphatidylinositol-4,5-bisphosphate was dissolved, and then filtering and sterilizing with a 0.22 μm filter membrane to obtain a phosphatidylinositol-4,5-bisphosphate solution; dissolving heat shock protein in a phosphate buffer solution at a pH value of 7.3, and then filtering and sterilizing with a 0.22 μm filter membrane to obtain a heat shock protein solution; lowering the temperature of the phosphatidylinositol-4,5-bisphosphate solution and the heat shock protein solution to 5°C, respectively, and then adding the heat shock protein solution and the pre-prepared exosomes to the phosphatidylinositol-4,5-bisphosphate solution under an inert gas and light-proof environment, wherein the mass ratio of exosomes, phosphatidylinositol-4,5-bisphosphate and heat shock protein is 1:0.5: 0.5, stirred and mixed, and incubated for 1.5 h. After the incubation, the solvent was filtered out and the exosomes were washed with sterile water to obtain modified exosomes; The method for preparing the exosome nasal spray comprises the following steps: (1) Add xanthan gum and sodium hyaluronate to sterile water and stir until dissolved to prepare a spray base solution; (2) Add a preservative and an antioxidant to the spray base liquid, stir evenly, adjust the pH value of the base liquid to 7.3, then add the modified exosomes thereto, stir and mix evenly, and fill to obtain the product.
[0025] Example 4 An exosome nasal spray, comprising the following raw materials in percentage by weight: 20% modified exosomes, 0.08% xanthan gum, 1.7% sodium hyaluronate, 0.08% benzyl alcohol, 1.5% anthocyanin, and the rest being sterile water; The modified exosomes were prepared by the following method: placing phosphatidylinositol-4,5-bisphosphate in a phosphate buffer solution at 37°C and a pH value of 7.3, stirring until the phosphatidylinositol-4,5-bisphosphate was dissolved, and then filtering and sterilizing with a 0.22 μm filter membrane to obtain a phosphatidylinositol-4,5-bisphosphate solution; dissolving heat shock protein in a phosphate buffer solution at a pH value of 7.3, and then filtering and sterilizing with a 0.22 μm filter membrane to obtain a heat shock protein solution; separating The temperature of the phosphatidylinositol-4,5-bisphosphate solution and the heat shock protein solution were lowered to 7°C, and then the heat shock protein solution and the pre-prepared exosomes were added to the phosphatidylinositol-4,5-bisphosphate solution under an inert gas and light-proof environment, wherein the mass ratio of the exosomes, phosphatidylinositol-4,5-bisphosphate and the heat shock protein was 1.5:0.6:1, and the mixture was stirred and mixed, and incubated together for 2 hours. After the incubation, the solvent was filtered out, and the exosomes were rinsed with sterile water to obtain modified exosomes; The method for preparing the exosome nasal spray comprises the following steps: (1) Add xanthan gum and sodium hyaluronate to sterile water and stir until dissolved to prepare a spray base solution; (2) Add a preservative and an antioxidant to the spray base liquid, stir evenly, adjust the pH value of the base liquid to 7.3, then add the modified exosomes thereto, stir and mix evenly, and fill to obtain the product.
[0026] Example 5 An exosome nasal spray, comprising the following raw materials in percentage by weight: 25% modified exosomes, 0.1% xanthan gum, 1.5% sodium hyaluronate, 0.1% benzyl alcohol, 2.5% anthocyanin, and the remainder being sterile water; The modified exosomes were prepared by the following method: placing phosphatidylinositol-4,5-bisphosphate in a phosphate buffer solution at 37°C and a pH value of 7.4, stirring until the phosphatidylinositol-4,5-bisphosphate was dissolved, and then filtering and sterilizing with a 0.22 μm filter membrane to obtain a phosphatidylinositol-4,5-bisphosphate solution; dissolving heat shock protein in a phosphate buffer solution at a pH value of 7.4, and then filtering and sterilizing with a 0.22 μm filter membrane to obtain a heat shock protein solution; lowering the temperature of the phosphatidylinositol-4,5-bisphosphate solution and the heat shock protein solution to 8°C, respectively, and then adding the heat shock protein solution and the pre-prepared exosomes to the phosphatidylinositol-4,5-bisphosphate solution under an inert gas and light-proof environment, wherein the mass ratio of exosomes, phosphatidylinositol-4,5-bisphosphate and heat shock protein is 2: 1: 1. Stir and mix, incubate for 3 hours, filter to remove the solvent after the incubation, and rinse the exosomes with sterile water to obtain modified exosomes; The method for preparing the exosome nasal spray comprises the following steps: (1) Add xanthan gum and sodium hyaluronate to sterile water and stir until dissolved to prepare a spray base solution; (2) Add a preservative and an antioxidant to the spray base liquid, stir evenly, adjust the pH value of the base liquid to 7.4, then add the modified exosomes thereto, stir and mix evenly, and fill to obtain a spray base liquid.
[0027] Comparative Example 1 An exosome nasal spray, comprising the following raw materials in percentage by weight: 25% exosomes, 0.1% xanthan gum, 1.5% sodium hyaluronate, 0.1% benzyl alcohol, 2.5% anthocyanidin, and the rest being sterile water; The method for preparing the exosome nasal spray comprises the following steps: (1) Add xanthan gum and sodium hyaluronate to sterile water and stir until dissolved to prepare a spray base solution; (2) Add a preservative and an antioxidant to the spray base liquid, stir evenly, adjust the pH value of the base liquid to 7.4, then add exosomes thereto, stir and mix evenly, and fill to obtain a spray base liquid.
[0028] The exosomes used in the above examples and comparative examples were prepared by existing methods and were derived from human umbilical cord blood.
[0029] Test example Taking the nasal spray prepared in Example 5 and Comparative Example 1 as an example, the filled and sealed spray was stored at 2°C. Before storage, 1 g of nasal spray was taken from each group and stained with trypan blue staining, and the exosome cells in the spray were counted as the number of exosomes in the nasal spray before storage. Then, 1 g of nasal spray was taken at 1 month, 2 months, 4 months, 6 months, 9 months and 12 months of storage, and the nasal spray was stained with trypan blue staining. The exosome cells in the spray were counted as the number of exosomes after storage; the survival rate of the exosomes was calculated, and the specific calculation results are shown in Table 1.
[0030] Exosome survival rate % = number of exosomes after storage / number of exosomes before storage * 100% Table 1: It can be seen from the data in the above table that the activity of the exosomes in the nasal spray prepared by the method in Example 5 is higher, and the activity of the exosomes decreases less with the extension of storage time; while the activity of the exosomes in the nasal spray prepared by the method in Comparative Example 1 is lower, and the activity of the exosomes decreases more with the extension of storage time, which proves that the nasal spray prepared by the method in the present application has higher activity and can prolong the storage time.
Claims
1. An exosome nasal spray, characterized in that: The raw materials include the following weight percentages: modified exosomes 15-30%, thickener 1-2%, preservative 0.01-0.1%, antioxidant 1-3%, and the rest is sterile water; Among them, the modified exosomes are prepared by the following method: using phosphate buffer as a solvent, preparing a phosphatidylinositol-4,5-bisphosphate solution and a heat shock protein solution respectively, and then mixing the two solutions under a low temperature, oxygen-free, and light-proof environment, adding exosomes to the mixed solution, stirring and mixing and incubating, and removing the solvent after the incubation to obtain modified exosomes.
2. The exosome nasal spray according to claim 1, characterized in that The invention comprises the following raw materials in percentage by weight: 25% of modified exosomes, 1.6% of thickener, 0.1% of preservative, 2.5% of antioxidant, and the rest of sterile water.
3. The exosome nasal spray according to claim 1, characterized in that During the preparation of the modified exosomes, the pH value of the phosphate buffer is 7.2-7.4; the incubation temperature after adding the exosomes is 4-8° C., and the incubation time is 1-3 h.
4. The exosome nasal spray according to claim 1, characterized in that The mass ratio of the exosomes, phosphatidylinositol-4,5-bisphosphate and heat shock protein is 1-2:0.5-1:0.5-1.
5. The exosome nasal spray according to claim 1, characterized in that The exosomes are human mesenchymal stem cell exosomes.
6. The exosome nasal spray according to claim 1, characterized in that The thickener includes xanthan gum and sodium hyaluronate, wherein the mass proportion of the xanthan gum in the nasal spray is 0.05-0.1%, and the mass proportion of the sodium hyaluronate in the nasal spray is 1-1.9%.
7. The exosome nasal spray according to claim 1, characterized in that The preservative is benzyl alcohol.
8. The exosome nasal spray according to claim 1, characterized in that The antioxidant is at least one of anthocyanidins, vitamin C and carotenoids.
9. The method for preparing the exosome nasal spray according to any one of claims 1 to 8, characterized in that: The following steps are involved: (1) Add a thickener to sterile water and stir until dissolved to prepare a spray base solution; (2) Add a preservative and an antioxidant to the spray base liquid, stir evenly, adjust the pH value of the base liquid to 7.2-7.4, then add the modified exosomes thereto, stir and mix evenly, and fill to obtain the product.
Citation Information
Patent Citations
Neural stem cell exosome nasal spray and preparation method thereof
CN113143968A
Nasal spray for allergic rhinitis and preparation method thereof
CN115029317A
Method for enhancing cellular uptake efficiency of exosome and application
CN115590969A
Nasal spray of exosome for treating allergic rhinitis and preparation method thereof
CN118319857A
Smart mobile moving mechanism for the stroller
KR1020240171598A
Cited By
Bone joint repairing composition containing stem cell vesicles and application thereof
CN119454759A
Exosome composition, application thereof and exosome eye drops
CN119524039A
